Home › Products › Nephrology › VyndaMx 61mg Capsule
VyndaMx 61mg Capsule
Salt Composition: TAFAMIDIS
- Manufacturer: PFIZER LTD
- Pack Size: 30 CAPSULE(s) IN A BOX
- Dosage Form: CAPSULE
- Strength: 61MG
- Prescription Required
- Storage: Store at room temperature between 20°C to 25°C (68°F to 77°F). Keep in the original packaging to protect from light and moisture. Keep out of reach of children and pets.
₹109688.00₹112500.00
Inclusive of all taxes
Product Introduction
Tafamidis is a medication containing the active ingredient tafamidis. It is used to treat transthyretin amyloid cardiomyopathy (ATTR-CM), a rare progressive condition affecting the heart. In this disease, abnormal protein deposits of transthyretin (TTR) accumulate in heart tissue, causing thickening and stiffening of the heart muscle, which may lead to heart failure. Tafamidis works by stabilising the transthyretin protein and preventing its breakdown and formation of amyloid deposits. This medication is prescribed to adults with wild-type or hereditary ATTR-CM. By slowing disease progression, tafamidis may help improve quality of life and reduce hospitalisations due to heart-related complications.
Uses
Tafamidis.NPP is approved for the following condition: Transthyretin amyloid cardiomyopathy (ATTR-CM), including: 1. Wild-type ATTR-CM 2. Hereditary ATTR-CM
How it works
Tafamidis.NPP works by binding to the transthyretin protein, which is responsible for transporting vitamin A and thyroxine in the blood. In transthyretin amyloidosis, this protein becomes unstable and misfolds, leading to amyloid deposits in organs, especially the heart. Tafamidis.NPP helps to stabilize the transthyretin protein and prevent it from breaking apart and forming amyloid fibrils. By doing so, Tafamidis.NPP reduces the formation of amyloid deposits in the heart, slows the progression of cardiomyopathy, and helps preserve heart function. It is not a cure, but it significantly delays the worsening of symptoms such as fatigue, shortness of breath, and swelling in the legs. It may also reduce the need for frequent hospital visits and improve daily functioning in patients with ATTR-CM.
How to Use
Tafamidis.NPP should be taken exactly as prescribed by your healthcare provider. It is usually taken once daily, preferably at the same time each day. The capsule should be swallowed whole with water and should not be opened or crushed. Tafamidis.NPP can be taken with or without food. If a dose is missed, take it as soon as you remember, unless itâs almost time for the next dose. Do not take two doses at once to make up for the missed dose.
Side Effects
Like all medications, Tafamidis.NPP can cause side effects, although not everyone experiences them. Serious: Liver function abnormalities Hypersensitivity reactions (rash, itching, swelling, or difficulty breathing) Common: Diarrhea Urinary tract infections Stomach pain Fatigue Upper respiratory tract infections Muscle cramps Dizziness
Expert Tips
Tafamidis.NPP is a breakthrough medication for managing transthyretin amyloid cardiomyopathy. It is essential to take this medicine consistently and attend regular follow-up appointments to monitor your heart health. Inform your doctor about all medications and supplements you are using. Since Tafamidis.NPP helps slow the disease but doesnât reverse existing heart damage, early diagnosis and treatment initiation are critical. Eat a heart-healthy diet, avoid excessive salt intake, and stay physically active as recommended. Regular monitoring and lifestyle adjustments can greatly improve your quality of life while on treatment.
References
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211996s002,212161s002lbl.pdf
- https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatments-heart-disease-caused-serious-rare-disease-transthyretin-mediated
- https://www.ema.europa.eu/en/documents/product-information/vyndaqel-epar-product-information_en.pdf
Safety Advice
Pregnancy: Consult your doctor Tafamidis.NPP is not recommended during pregnancy. There is insufficient data on its safety for unborn babies. Women of childbearing potential should use effective contraception during treatment and consult their doctor if planning a pregnancy
Lungs: Consult your doctor Not Known
Breastfeeding: Consult your doctor It is unknown whether Tafamidis.NPP passes into breast milk. Due to potential risk to the infant, breastfeeding is not advised while using this medication.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.